GBT 440-007 A Phase 2a, Open-label, Single and Multiple Dose Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Exploratory Treatment Effect of GBT440 in Adolescents with Sickle Cell Disease
- Liem, Robert I (PD/PI)
Project: Research project